FDA Drug information
INVOKANA
Up to date, easily accessible information about drugs approved by the US Food & Drug Administration (FDA)
- INVOKANA CANAGLIFLOZIN 100 mg/1 A-S Medication Solutions
- INVOKANA CANAGLIFLOZIN 100 mg/1 Cardinal Health 107, LLC
- INVOKANA CANAGLIFLOZIN 100 mg/1 Cardinal Health 107, LLC
- INVOKANA CANAGLIFLOZIN 100 mg/1 Janssen Pharmaceuticals, Inc.
- INVOKANA CANAGLIFLOZIN 300 mg/1 A-S Medication Solutions
- INVOKANA CANAGLIFLOZIN 300 mg/1 Cardinal Health 107, LLC
- INVOKANA CANAGLIFLOZIN 300 mg/1 Cardinal Health 107, LLC
- INVOKANA CANAGLIFLOZIN 300 mg/1 Janssen Pharmaceuticals, Inc.
Learning Zones
Disclaimer
The drug Prescribing Information (PI), including indications, contra-indications, interactions, etc, has been developed using the U.S. Food & Drug Administration (FDA) as a source (www.fda.gov).
Medthority offers the whole library of PI documents from the FDA. Medthority will not be held liable for explicit or implicit errors, or missing data.
Drugs appearing in this section are approved by the FDA. For regions outside of the United States, this content is for informational purposes only and may not be aligned with local regulatory approvals or guidance.